BRD4 and leukemia: I-BET151 is a compound that inhibits the bromodomain and extra terminal (BET) protein BRD4 and was previously reported to be particularly efficient on KMT2A-r leukemias (Dawson et al., 2011; Zuber et al., 2011), confirming the robustness of our high-throughput screening.